Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ACTRN12626001159347) titled 'Tolerability of administration of cyclopentolate 1% eye drops in healthy adults: Study 1 ' on Sept. 17.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Crossover
Type of endpoint: Efficacy
Primary Sponsor: Queensland University of Technology
Condition:
Cycloplegia
Cycloplegia
Eye - Normal eye development and function
Intervention:
What is the drug/intervention: Cyclopentolate Hydrochloride 1% eye drops - micro drop and spray administration of TGA approved products
Dose: 1-2 drops (or spray doses) per eye ...